There is an increased risk of 30-day postoperative renal complications, wound complications, and unplanned hospital readmissions in patients with metabolic syndrome undergoing elective surgery for colorectal cancer (CRC), a new study found. 30-day postoperative mortality and morbidity, unplanned reoperation, unplanned readmission, operative time, and length of stay (LOS) were measured. Among the findings:
- Of 91,566 patients analyzed, 7,603 (8.3%) had metabolic syndrome.
- Metabolic syndrome was associated with an increased risk of 30-day overall morbidity, pulmonary complications, renal complications, septic complications, cardiac complications, would complications, blood transfusion, longer LOS, and unplanned readmissions.
- On multivariable analysis, metabolic syndrome remained significantly associated with renal complications, superficial surgical site infection, wound dehiscence, and unplanned readmissions.
Shariq OA, Hanson KT, McKenna NP, et al. Does metabolic syndrome increase the risk of postoperative complications in patients undergoing colorectal cancer surgery? [Published online ahead of print January 31, 2019]. Dis Colon Rectum.